Summary
Nitric oxide (NO) is known to be critically involved in breast carcinogenesis. Genetic polymorphisms of the gene encoding for endothelial nitric oxide synthase (Nos3), the enzyme catalyzing the production of the NO, are known to predispose to malignant disease. Whether these polymorphisms also influence breast cancer risk is unknown. In the present case–control study, we ascertained 2 polymorphisms of the Nos3 gene cluster (Nos3 exon 7 Glu298Asp and a 27-base pair repeat in intron 4 of Nos3) in 269 Caucasian patients with breast cancer and 244 healthy controls using pyrosequencing and PCR, respectively. Presence of the exon 7 Nos3 polymorphism predisposed women to breast cancer (p=0.03, Odds ratio [95% Confidence Intervals]=1.9 [1.1–3.6]), but was not associated with any clinico-pathological parameters. No significant associations were ascertained with respect to the intron 4 Nos3 polymorphism. In our series, presence of the mutant exon7 Nos3 polymorphism was associated with an increased risk for breast cancer in Caucasian women.
Similar content being viewed by others
References
Moncada S, Higgs A. (1993) The l-arginine-nitric oxide pathwayN Engl J Med 329:2002–2012
Gatti G, Simsek S, Zurrida S, Kurne A, Giannetti I, Demirer S, Smeets A, Caldarella P, Vento AR, Giraldo A, Luini A. 2004 Possible role of nitric oxide in the biology of breast carcinoma: review of the available literatureBreast 13: 1–6
Farias-Eisner R, Sherman MP, Aeberhard E, Chaudhuri G. 1994 Nitric oxide is an important mediator for tumoricidal activity in vivoProc Natl Acad Sci USA 91: 9407–9411
Jadeski LC, Chakraborty C, Lala PK. 2003 Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinaseInt J Cancer 106: 496–504
Jadeski LC, Chakraborty C, Lala PK.2002 Role of nitric oxide in tumour progression with special reference to a murine breast cancer modelCan J Physiol Pharmacol 80: 125–135
Lala PK, Orucevic A 1999 Role of nitric oxide in tumor progression: lessons from experimental tumorsCancer Metastasis Rev 17: 91–106
Thomsen LL, Miles DW. 1998 Role of nitric oxide in tumour progression: lessons from human tumoursCancer Metastasis Rev 17: 107–118
Orucevic A, Bechberger J, Green AM, Shapiro RA, Billiar TR, Lala PK. 1999 Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasivenessInt J Cancer 81: 889–896
Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, Mitchell JB. 1998 The multifaceted roles of nitric oxide in cancerCarcinogenesis 19: 711–721
Jadeski LC, Lala PK. 1999 Nitric oxide synthase inhibition by N(G)-nitro-l-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumorsAm J Pathol 155: 1381–1390
Coskun U, Gunel N, Sancak B, Gunel U, Onuk E, Bayram O, Yilmaz E, Candan S, Ozkan S. 2003 Significance of serum vascular endothelial growth factor, insulin-like growth factor-I levels and nitric oxide activity in breast cancer patientsBreast 12: 104–110
Simeone AM, Deng CX, Kelloff GJ, Steele VE, Johnson MM, Tari AM. 2005 N-(4-hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated brest cancer cellsCarcinogenesis 26: 1000–1007
Lahiri M, Martin JH. 2004 Reduced expression of endothelial and inducible nitric oxide synthase in a multidrug resistant variant of the MCF-7 human breast cancer cell lineOncol Rep 12: 1007–1011
Coskun U, Gunel N, Sancak B, Onuk E, Bayram M, Cihan A. 2004 Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patientsClin Exp Immunol 137: 546–551
Martin JH, Alalami O, van den Berg HW. 1999 Reduced expression of endothelial and inducible nitric oxide synthase in a human breast cancer cell line which has acquired estrogen independenceCancer Lett 144:65–74
Martin JH, Begum S, Alalami O, Harrison A, Scott KW. 2000 Endothelial nitric oxide synthase: correlation with histologic grade, lymph node status and estrogen receptor expression in human breast cancerTumour Biol 21: 90–97
Reveneau S, Arnould L, Jolimoy G, Hilpert S, Lejeune P, Saint-Giorgio V, Belichard C, Jeannin JF. 1999 Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptorsLab Invest 79: 1215–1225
Mortensen K, Holck S, Christensen IJ, Skouv J, Hougaard DM, Blom J, Larsson LI. 1999 Endothelial cell nitric oxide synthase in peritumoral microvessels is a favorable prognostic indicator in premenopausal breast cancer patientsClin Cancer Res 5: 1093–1097
Vakkala M, Paakko P, Soini Y. 2000 eNOS expression is associated with the estrogen and progesterone receptor status in invasive breast carcinomaInt J Oncol 17: 667–671
Zeillinger R, Tantscher E, Schneeberger C, Tschugguel W, Eder S, Sliutz G, Huber JC. 1996 Simultaneous expression of nitric oxide synthase and estrogen receptor in human breast cancer cell linesBreast Cancer Res Treat 40: 205–207
Xu W, Charles IG, Moncada S, Gorman P, Sheer D, Liu L, Emson P. 1994 Mapping of the genes encoding human inducible and endothelial nitric oxide synthase (NOS2 and NOS3) to the pericentric region of chromosome 17 and to chromosome 7, respectivelyGenomics 21: 419–422
Shimasaki Y, Yasue H, Yoshimura M, Nakayama M, Kugiyama K, Ogawa H, Harada E, Masuda T, Koyama W, Saito Y, Miyamoto Y, Ogawa Y, Nakao K. 1998 Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarctionJ Am Coll Cardiol 31: 1506–1510
Yoshimura T, Yoshimura M, Tabata A, Shimasaki Y, Nakayama M, Miyamoto Y, Saito Y, Nakao K, Yasue H, Okamura H. 2000 Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsiaJ Soc Gynecol Investig 7: 238–241
Hefler LA, Tempfer CB, Bashford MT, Unfried G, Zeillinger R, Schneeberger C, Koelbl H, Nagele F, Huber JC. 2002 Polymorphisms of the angiotensinogen gene, the endothelial nitric oxide synthase gene, and the interleukin-1beta gene promoter in women with idiopathic recurrent miscarriageMol Hum Reprod 8: 95–100
Riener EK, Hefler LA, Grimm C, Galid A, Zeillinger R, Tong-Cacsire D, Gitsch G, Leodolter S, Tempfer CB. 2004 Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancerGynecol Oncol 93:686–690
Hefler LA, Ludwig E, Lampe D, Zeillinger R, Leodolter S, Gitsch G, Koelbl H, Tempfer CB. 2002 Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancerGynecol Oncol 86: 134–137
Ghilardi G, Biondi ML, Cecchini F, DeMonti M, Guagnellini E, Scorza R. 2003 Vascular invasion in human breast cancer is correlated to T(786C polymorphism of NOS3 geneNitric Oxide 9: 118–122
Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N. 1998 Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJ Natl Cancer Inst 90: 1371–1388
Powles T, Eeles R, Ashley S, Easton D, Chang J, Dowsett M, Tidy A, Viggers J, Davey J. 1998 Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialLancet 352: 98–101
Hefler LA, Tempfer CB, Grimm C, Lebrecht A, Ulbrich E, Heinze G, Leodolter S, Schneeberger C, Mueller MW, Muendlein A, Koelbl H. 2004 Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian womenCancer 101: 264–269
Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY. 1999 Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibilityCancer Res 59: 4870–4875
Kammerer S, Roth RB, Reneland R, Marnellos G, Hoyal CR, Markward NJ, Ebner F, Kiechle M, Schwarz-Boeger U, Griffiths LR, Ulbrich C, Chrobok K, Forster G, Praetorius GM, Meyer P, Rehbock J, Cantor CR, Nelson MR, Braun A. 2004 Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locusCancer Res 64: 8906–8910
Phillips CV, Goodman KJ. 2004 The missed lessons of Sir Austin Bradford HillEpidemiol Perspect Innov 1: 3–7
Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. 2000 Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298Proc Natl Acad Sci USA 97: 2832–2835
Acknowledgements
We thank Grazyna Dudek, Eva Schuster, and Andrea Wolf for technical assistance.
Financial support: Ludwig Boltzmann Institute of Gynecology and Gynecologic Oncology, Vienna, Austria.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hefler, L.A., Grimm, C., Lantzsch, T. et al. Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer. Breast Cancer Res Treat 98, 151–155 (2006). https://doi.org/10.1007/s10549-005-9143-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-9143-2